Insider · CIK 0001495411
Keith A. Goldan
Files at ABEO (ABEONA THERAPEUTICS INC.), SNDX (Syndax Pharmaceuticals Inc). First filing Feb 12, 2025, latest Feb 10, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SNDX: Syndax Pharmaceuticals Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | Syndax Pharmaceuticals Inc | $72k 3,410 shares | -2% | +143% from low-4% from high | |
| 36Weak | Syndax Pharmaceuticals Inc | $43k 2,082 shares | -1% | +141% from low-5% from high | |
| 30Weak | Syndax Pharmaceuticals Inc | $12k 1,296 shares | -1% | +6% from low-58% from high | |
| 37Weak | Syndax Pharmaceuticals Inc | $59k 3,777 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | ABEO ABEONA THERAPEUTICS INC. | AGrant or award Common Stock | +32,751 | $0.00 | $0 | 32,751 | Apr 7, 2026 |
| Feb 9, 2026 | SNDX Syndax Pharmaceuticals Inc | SOpen-market sale Common Stock | -3,410 | $21.03 | $72k | 140,429 | Feb 10, 2026 |
| Jan 30, 2026 | SNDX Syndax Pharmaceuticals Inc | JOther Common Stock | +1,219 | $8.48 | $10k | 93,671 | Feb 6, 2026 |
| Feb 4, 2026 | SNDX Syndax Pharmaceuticals Inc | AGrant or award Common Stock | +21,500 | $0.00 | $0 | 115,171 | Feb 6, 2026 |
| Feb 4, 2026 | SNDX Syndax Pharmaceuticals Inc | AGrant or award Common Stock | +30,750 | $0.00 | $0 | 145,921 | Feb 6, 2026 |
| Feb 6, 2026 | SNDX Syndax Pharmaceuticals Inc | SOpen-market sale Common Stock | -2,082 | $20.62 | $43k | 143,839 | Feb 6, 2026 |
| Feb 4, 2026 | SNDX Syndax Pharmaceuticals Inc | AGrant or award Stock Options (Right to buy)derivative | +118,000 | $20.43 | $2.4M | 118,000 | Feb 6, 2026 |
| Dec 1, 2025 | SNDX Syndax Pharmaceuticals Inc | GGift Common Stock | -1,224 | $0.00 | $0 | 92,452 | Dec 1, 2025 |
| Jul 31, 2025 | SNDX Syndax Pharmaceuticals Inc | JOther Common Stock | +1,226 | $8.43 | $10k | 93,676 | Aug 7, 2025 |
| Jul 16, 2025 | SNDX Syndax Pharmaceuticals Inc | SOpen-market sale Common Stock | -1,296 | $9.29 | $12k | 92,450 | Jul 18, 2025 |
| May 19, 2025 | SNDX Syndax Pharmaceuticals Inc | POpen-market purchase Common Stock | +3,000 | - | - | 93,746 | May 19, 2025 |
| Feb 10, 2025 | SNDX Syndax Pharmaceuticals Inc | SOpen-market sale Common Stock | -3,777 | $15.50 | $59k | 90,746 | Feb 12, 2025 |
| Feb 5, 2025 | SNDX Syndax Pharmaceuticals Inc | AGrant or award Common Stock | +18,500 | $0.00 | $0 | 71,123 | Feb 7, 2025 |
| Feb 5, 2025 | SNDX Syndax Pharmaceuticals Inc | AGrant or award Common Stock | +23,400 | $0.00 | $0 | 94,523 | Feb 7, 2025 |
| Feb 5, 2025 | SNDX Syndax Pharmaceuticals Inc | AGrant or award Stock Options (Right to buy)derivative | +110,500 | $14.65 | $1.6M | 110,500 | Feb 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.